Related Experiment Video
Updated: Jun 12, 2026
Quantification of three DNA Lesions by Mass Spectrometry and Assessment of Their Levels in Tissues of Mice Exposed to Ambient Fine Particulate Matter
Published on: May 29, 2019
Thin layer chromatography-based assay of O6-methylguanine-DNA methyltransferase activity in tissue
Cliff Robinson1, Juan Palomo, Michael A Vogelbaum
1Department of Radiation Oncology, Washington University in St. Louis, St. Louis, MO 63110, USA.
Abstract:
Expression of the DNA repair enzyme O(6)-methylguanine-DNA methyltransferase (MGMT) in tumor correlates with resistance to alkylating agents, and depletion of MGMT activity can enhance chemotherapy-induced tumor cytotoxicity. The most common assays of MGMT activity are time-consuming and employ radioactivity. The assay described here uses a fluorescently labeled O(6)-benzylguanine derivative in conjunction with thin layer chromatography to eliminate the use of radioactivity and allows MGMT activity to be rapidly measured in minimally prepared cell or tissue extracts.
Insights
A new assay rapidly measures O(6)-methylguanine-DNA methyltransferase (MGMT) activity without radioactivity. This method can help predict patient response to chemotherapy by assessing tumor resistance to alkylating agents.
Area of Science:
- Molecular Biology
- Biochemistry
- Pharmacology
Background:
- Tumor expression of O(6)-methylguanine-DNA methyltransferase (MGMT) is linked to resistance against alkylating chemotherapy agents.
- Reducing MGMT activity can increase the effectiveness of chemotherapy against tumors.
- Current methods for measuring MGMT activity are often slow and involve radioactivity.
Purpose of the Study:
- To develop a novel, rapid, and non-radioactive assay for quantifying MGMT activity.
- To provide a tool for assessing tumor resistance to alkylating agents and guiding chemotherapy decisions.
Main Methods:
- Utilized a fluorescently labeled O(6)-benzylguanine derivative as a substrate.
- Employed thin-layer chromatography for separation and detection.
- Applied the assay to minimally prepared cell or tissue extracts.
Main Results:
- Successfully measured MGMT activity rapidly and without the need for radioactivity.
- The assay is applicable to cell and tissue extracts with minimal preparation.
- Demonstrated a viable alternative to traditional, time-consuming radioactive assays.
Conclusions:
- The developed fluorescent assay provides a fast, safe, and efficient method for determining MGMT activity.
- This assay can be a valuable tool in clinical settings for predicting chemotherapy response and optimizing treatment strategies.
- Facilitates research into MGMT's role in drug resistance and the development of novel therapeutic approaches.
